Filter News

Watson Pharmaceuticals, Inc. To Host Meeting To Discuss Fourth Quarter And Full Year 2003 Results

Published: Jan 30, 2004

CORONA, Calif., Jan. 29 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that it will host a meeting with financial analysts at 5:00 p.m. Eastern Standard Time on Thursday, February 5, 2004. Watson's senior management will discuss the Company's fourth quarter and full year 2003 financial results, outlook for 2004 and recent corporate events. The Company plans to release its earnings and outlook on February 5, 2004, following the close of the U.S. financial markets.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO )

The meeting will be webcast live, and can be accessed by logging onto http://www.watsonpharm.com/ and selecting the analyst conference icon link displayed on the home page, as well as in the Investors section. A live audio broadcast of the analyst meeting can also be accessed by dialing (877) 251-7980, or from international locations, dial (706) 643-1573.

An audio replay of the meeting will also be available beginning approximately two hours after the meeting's conclusion and will remain available through 12:00 midnight Eastern Standard Time on February 12, 2004. The replay may be accessed by dialing (800) 642-1687 and entering access code 5009620. From international locations, the replay may be accessed by dialing (706) 645-9291 and entering the same access code. A replay of the webcast will also be available on Watson's Web site.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets and distributes branded and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watsonpharm.com/.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, photodesk@prnewswire.comWatson Pharmaceuticals, Inc.

CONTACT: Investors, Patty Eisenhaur, +1-909-493-5611, or Media, ChrisEso, +1-909-493-4013, both of Watson Pharmaceuticals, Inc.

Back to news